|
HY-N6937-10mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-20mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-5mg
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6937-1mL
|
MedChemexpress LLC
|
(R,R)-Secoisolariciresinol diglucoside [CAS 158932-33-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-66011B-1mg
|
MedChemexpress LLC
|
(Rac)-Moxifloxacin [CAS 354812-41-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-34350-1g
|
MedChemexpress LLC
|
2-(Aminomethyl)phenol [CAS 932-30-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-34350-500mg
|
MedChemexpress LLC
|
2-(Aminomethyl)phenol [CAS 932-30-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P7125-10ug
|
MedChemexpress LLC
|
4-1BB/TNFRSF9, Human
|
|
COVID-19-immunoregulation
|
|
|
HY-P7125-50ug
|
MedChemexpress LLC
|
4-1BB/TNFRSF9, Human
|
|
COVID-19-immunoregulation
|
|
|
HY-B0283-100mg
|
MedChemexpress LLC
|
Acipimox [CAS 51037-30-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0283-50mg
|
MedChemexpress LLC
|
Acipimox [CAS 51037-30-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0283-1mL
|
MedChemexpress LLC
|
Acipimox [CAS 51037-30-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-10mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-100mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-200mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-5mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-50mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-500mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-16040-1mL
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-150514-10mg
|
MedChemexpress LLC
|
ARN1468 [CAS 1381459-14-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-150514-100mg
|
MedChemexpress LLC
|
ARN1468 [CAS 1381459-14-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-150514-25mg
|
MedChemexpress LLC
|
ARN1468 [CAS 1381459-14-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-150514-5mg
|
MedChemexpress LLC
|
ARN1468 [CAS 1381459-14-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-150514-50mg
|
MedChemexpress LLC
|
ARN1468 [CAS 1381459-14-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-137553-1mg
|
MedChemexpress LLC
|
Beta-Aminoarteether [CAS 133162-24-0]
|
|
COVID-19-immunoregulation
|
|
